Axogen, Inc Reports 2022 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
AxoGen (AXGN) Tops Q2 EPS by 9c; Reaffirms FY22 Guidance
August 3, 2022 4:36 PM EDTAxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.06), $0.09 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $34.5 million versus the consensus estimate of $33.82 million.
GUIDANCE:
AxoGen sees FY2022 revenue of $135-142 million, versus the consensus of $139.3... More
